Cj Delgra

CJ Delgra is a seasoned professional in the field of pharmacovigilance with a robust background in safety operations and medical review. Currently serving as a Strategic Pharmacovigilance Advisor at Perspective Pharmacovigilance, Inc. since April 2022, CJ has held prominent roles at major pharmaceutical companies, including Vice President of ICSR Case Management at BeiGene and Executive Director of Worldwide Patient Safety at Bristol-Myers Squibb. With previous leadership positions in drug safety and regulatory affairs at Celgene, Merck, Amgen, and Genentech, CJ has developed extensive expertise in medical safety review, case management, and aggregate safety reporting. CJ holds an MD from the West Virginia University School of Medicine and a BA in Biology from West Virginia University.